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ABSTRACT
Telomere fusion is an important mutational
event that has the potential to lead to large-scale
genomic rearrangements of the types frequently
observed in cancer. We have developed single-
molecule approaches to detect, isolate and charac-
terize the DNA sequence of telomere fusion events
in human cells. Using these assays, we have
detected complex fusion events that include fusion
with interstitial loci adjacent to fragile sites,
intra-molecular rearrangements, and fusion events
involving the telomeres of both arms of the same
chromosome consistent with ring chromosome
formation. All fusion events were characterized by
the deletion of at least one of the telomeres
extending into the sub-telomeric DNA up to 5.6kb;
close to the limit of our assays. The deletion profile
indicates that deletion may extend further into the
chromosome. Short patches of DNA sequence
homology with a G:C bias were observed at the
fusion point in 60% of events. The distinct profile
that accompanies telomere fusion may be a charac-
teristic of the end-joining processes involved in the
fusion event.
INTRODUCTION
By capping the ends of linear chromosomes and prevent-
ing fusion, telomeres play a key role in upholding chro-
mosomal integrity. The loss of the end-capping function
can occur as a consequence of gradual telomere erosion or
stochastic telomeric deletion; both of which can create
short dysfunctional telomeres (1–3). The end-capping
function can also be abrogated by the experimental dis-
ruption of the telomeric protein structure, which creates
telomeres that are dysfunctional, but full length (4). The
loss of telomere function can result in the fusion of
telomeres with other telomeric loci, or non-telomeric
double-stranded DNA breaks; this can result in the for-
mation of dicentric chromosomes. With ongoing cell
division the resulting cycles of anaphase-bridging,
breakage and fusion can result in genomic rearrangements
such as non-reciprocal translocations (NRTs) and
localized ampliﬁcations that are common in a broad
spectrum of tumour types (5–8). It is thus considered
that telomere dysfunction may facilitate progression in
the early stages of tumourigenesis. Consistent with this,
telomere length is reduced in some types of carcinoma
compared to matched normal tissue (9–11) and an
increase in anaphase-bridging, a surrogate marker of
telomere fusion, is detected at the adenoma-carcinoma
transition, a point that is characterized by increased
chromosomal instability in colorectal carcinoma (12),
breast (13) and oral squamous cell carcinomas (14).
Furthermore, breakpoint frequency and telomere length
is negatively correlated at speciﬁc chromosome ends in
some carcinoma derived cells (15–17). These data are
backed up by evidence from telomerase knockout mouse
models, which show that telomere loss correlates with
genomic instability which may drive a higher rate of
tumour formation and a lower age of onset (18,19).
Carcinomas from telomerase knockout mice contain
high frequencies of chromosomes lacking telomeric
signals, anaphase bridges, NRTs and end-to-end
fusions (6).
If the telomere repeat array and the subtelomeric
sequences remain intact, telomere fusion between sister
chromatids will generate inverted repeats that may
create fragile sites, such that a subsequent breakage may
then occur close to the site of the original telomere fusion
(20): a second round sister chromatid fusion of the broken
chromosome, may then result in further ampliﬁcation.
Thus, in addition to large-scale genomic rearrangements,
*To whom correspondence should be addressed. Tel: +44 0 29 2068 7038; Fax: +44 0 29 2068 7343; Email: bairddm@cardiﬀ.ac.uk
Published online 21 December 2009 Nucleic Acids Research, 2010, Vol. 38, No. 6 1841–1852
doi:10.1093/nar/gkp1183
 The Author(s) 2009. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.such as NRTs, sister chromatid telomere fusion and
cycles of anaphase-bridging, breakage and fusion can
result in localized gene ampliﬁcation (21). Hence, short
dysfunctional telomeres have the potential to create the
types of mutation that may drive progression in the
early stages of cancer, it is therefore of interest to under-
stand the mechanistic basis of telomere fusion in human
cells.
Experimental intervention in the protein structure of the
telomere, such as abrogating the function of TRF2, results
in immediate telomeric de-protection and fusion that is
dependent upon factors required for non-homologous
end-joining (NHEJ), including ligase IV, DNA PKcs
and Ku (22,23). However in contrast, the fusion of short
dysfunctional telomeres in telomerase mutants of Yeast,
Arabidopsis and mice is independent of Ku70, DNA-PKcs
and Ligase IV (1,24–26). These data imply that critically
shortened telomeres may be subjected to fusion that is
mediated by alternative end-joining mechanisms. We
have investigated fusion between short dysfunctional
telomeres in human cells using a PCR-based assay that
detects single-molecule telomere fusion events. This
revealed that fusion was accompanied by deletion and
short patches of homology at the fusion point (2). We
have now expanded this assay, which was previously
based on just two chromosome ends, to include at least
43% of telomeres in the human genome. Sequence
analysis of a large set of telomere fusion events revealed
more extensive sub-telomeric deletions that extend up to
the limit of our assays (6.1kb) that are consistent with
error-prone DNA-PK independent end-joining (27–30).
In addition, fusion events were characterized by short
patches of homology at the fusion point that exhibited a
G:C bias. We also observed events that may result in
large-scale genomic rearrangements, including, fusion
events that are consistent with chromosome circulariza-
tion, fusion with interstitial telomeres, and intra-molecular
fusion prior to chromosomal fusion.
MATERIALS AND METHODS
Cell culture
Telomerase expressing HEK293 cells that were originally
derived from human embryonic kidney cells transformed
with adenoviral DNA (31), were cultured in 88%
Dulbecco’s Modiﬁed Eagle’s Medium (DMEM; contain-
ing 4500mg/l D-glucose, 110mg/l sodium pyruvate, and
non-essential amino acids but no L-glutamine), supple-
mented with 10% (v/v) Foetal Calf Serum, 1 10
5IU/l
penicillin, 100mg/l streptomycin and 2mM glutamine.
Telomerase negative MRC5 clonal ﬁbroblasts expressing
human papillomavirus oncoproteins E6 E7 used in this
study have been described previously (2). We deﬁned the
onset of replicative senescence (M1) as at least 2 weeks of
no cell growth and BrdU labelling indices of <1% .M 2
‘crisis’ was deﬁned as when the cell culture ceases to
expand following replicative span extension beyond senes-
cence (32).
DNA extraction
Genomic DNA was extracted by standard proteinase K,
RNase A and phenol/chloroform protocols (33). High
molecular weight DNA was solubilized by either digesting
with EcoRI or serial dilutions in 10mM Tris–HCl (pH
8.0) to  100ng/ml, prior to quantifying the DNA in trip-
licate by Hoechst 33258 ﬂuorometry.
Telomere fusion assay
Several primers were designed within the sub-telomeric
repeat regions that are shared among multiple chro-
mosomes. Primers that target some of the TelBamII and
TelBam 3.4 classes of subtelomeric repeat regions (34–36)
were designed using the 21q and 16p telomere-adjacent
sequences respectively (35).
The telomere fusion assay was then carried out as
described previously (2) with the following modiﬁcations.
The EcoRI solubilized DNA was used in the assay with
the 21q group primers and 100ng/ml Tris diluted DNA for
the 16p group primers. PCR reactions to detect fusion
involving the 21q group telomeres were undertaken with
XpYpM/17p6 and 21q1 and for the 16p group with
XpYpM/17p6 and 16p1 primers. Fusion molecules were
detected and the frequencies quantiﬁed by Southern
blotting and hybridization with the XpYp and 17p
telomere-adjacent probes as described previously (2).
In order to determine the chromosomes participating in
the fusion events for subsequent sequence characteriza-
tion, further hybridizations were undertaken with the
21q or 16p telomere-adjacent probes generated by PCR
with 21qseq1/21qseq1rev or the 16p2/16pseq1rev PCR
primers (Figure 1A), these probes yield additional
non-speciﬁc products and thus were not used for quanti-
ﬁcation. Any fusion products were then re-ampliﬁed for
direct sequence analysis using nested PCR primers
(XpYpO, 17p7, 21qseq1 and 16p2, Figure 1A) as
determined by Southern hybridization, as described
previously (2).
To provide an estimate of the frequency of fusion, the
total number of bands generated from each DNA
analysed was counted and the number of input molecules
in each analysis was estimated from the amount of DNA
used in each reaction together with the size of a diploid
human genome. Thus, the frequency of fusion could be
calculated from the number of positive molecules
compared to the number of input molecules. This will
represent an underestimate of the total telomere fusion
frequency as the fusion assays described here are capable
of detecting a small fraction of the total number of diﬀer-
ent pair wise telomere fusion combinations in the human
genome.
Oligonucleotides
XpYp and 17p primers used during this study have been
described previously (2). The chromosome ends that
previously hybridized to the TelBam11 probe (21q, 1q,
2q, 5q, 6q, 6p, 8p, 10q, 13q, 17q, 19p, 19q, 22q and the
2q13 interstitial telomeric locus) and to the TelBam3.4
probe (16p, 1p, 9p, 12p, 15q, XqYq ant the 2q14
1842 Nucleic Acids Research, 2010,Vol.38, No. 6interstitial locus) probes (34,36) were termed 21q and 16p
groups, respectively (Figure 1A). The primers for the
telomere fusion assay were designed for both groups
within the sub-telomeric regions of the 21q and 16p
sequences (35,36) (Table 1).
RESULTS
Telomere fusion assay
We have previously developed a single-molecule
PCR-based telomere fusion assay for two chromosome
ends, XpYp and 17p. The sub-telomeric sequence of
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Figure 1. Illustrating the single molecule telomere fusion assay. (A) Diagrammatic representation of oligonucleotide primers used for the PCR
reaction; the XpYp and 17p primers are speciﬁc to those chromosome end; the 21q group primers are capable of amplifying the telomeres of 1q, 2q,
5q, 6q, 6p, 8p, 10q, 13q, 19p, 19q, 21q, 22q and 2q13; the 16p group ampliﬁes the telomeres of 1p, 9p, 12p, 15q 16p and XqYq as well as the 2q14.
(B) Examples of telomere fusion gels, showing the improvement in the sensitivity of the PCR reaction when the additional telomeres are included
in the reaction, as indicated on the left. HEK293, and MRC5 E6E7 with population doublings (PD), are indicated above. Each reaction contains
100ng of DNA, and the fusion products were detected with the XpYp telomere adjacent probe. The frequency at which fusion was detected is
indicated below each analysis, molecular weight markers are indicated on the right.
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sequence-speciﬁc telomere length and fusion assays have
been developed (2,37–39). However, the analysis of fusion
between just two chromosome ends is limiting; increasing
the scope of the assay to include more ends will improve
the sensitivity and allow the detection of rare fusion
events; which will be important in examining telomere
fusion directly from human tissue in both normal and
disease contexts. It will also allow the detection of
a broader range of fusion structures and the identiﬁca-
tion of speciﬁc chromosome ends in the human genome
that are subjected to fusion. We therefore chose to
expand the scope of this assay by including PCR
primers based within the complex subtelomeric sequences
that are shared between multiple chromosome ends (40).
Two subtelomeric sequence families were chosen for
analysis; one family included the telomeres of 21q, 1q,
2q, 5q, 6q, 6p, 8p, 10q, 13q, 17q, 19p, 19q, 22q and the
2q13 interstitial telomeric locus representing some of the
telomeres detected with the TelBam 11 sequence (41);
the other family included the 16p, 1p, 9p, 12p, 15q and
XqYq telomeres, as well as the 2q14 interstitial locus (42),
representing telomeres detected with the TelBam3.4
sequence (35,36,41) (Figure 1A). We refer to these
telomere families as the 21q and 16p telomere groups,
respectively.
A valuable aspect of these assays is the ability to char-
acterize the DNA sequence of fusion events; this provides
veriﬁcation that the fusion events are genuine, and allows
one to examine the underlying biology. However, fusion
within the 21q or the 16p telomere family members is
likely to result in the creation of palindromic sequences
and it is not practical to sequence these events directly.
Thus, for the initial development of the assay we used
PCR primers targeted to the 21q and 16p family in con-
junction with the speciﬁc chromosome ends XpYp and
17p. To validate the assay, we used HEK293 cells which
we had previously shown to exhibit fusion between the
XpYp and 17p telomeres at a high frequency (2).
HEK293 cells express telomerase but maintain telomere
length distributions that extend to within the length
range that we had previously detected fusion events (2).
Combining the 17p, XpYp and 21q primers resulted in
an increase (2.9 ) in the number of fusions detected
(Figure 1B); an increase in the number of fusion events
was also observed when combining 17p, XpYp and 16p
primers (data not shown). The combination of XpYp,
17p, 21q and 16p resulted in a further increase (4 )i n
the number of detectable fusion events (Figure 1B).
Given the apparent success of these assays we then
applied them to a clonal MRC5 ﬁbroblast culture in
which we had expressed HPVE6E7 oncoproteins (2). We
have previously described that, in this culture, as the cells
continued to divide beyond the point of senescence the
telomeres continue to erode to a threshold length at
which fusion events were detected between the XpYp
and 17p telomeres (2). Crucially, there was no detectable
change in telomere dynamics (erosion rates or frequencies
of sporadic deletion) following HPVE6E7 expression (2).
Using the 16p and 21q assays we observed a similar
increase in the number of detectable fusion events with
ongoing cell division through to the point of ‘crisis’,
overall there was an increase in the number of detectable
fusion events compared to that observed with the XpYp/
17p fusion analysis alone (Figure 1B). The number of
fusion events was so great in the MRC5 E6E7 cells under-
going ‘crisis’ that it appeared to interfere with the ampli-
ﬁcation creating some smearing on the gels, which was
not apparent in samples with small numbers of fusions
(Figure 1B).
The increase in the number of detectable fusion events
with the modiﬁed assays indicated that we were detecting
fusion between additional chromosome ends. In order
to verify this and to examine the mutational spectrum,
we undertook direct sequence analysis of single fusion
events isolated from both HEK293 and MRC5 cells
(Figure 2). The telomeres participating in each fusion
event were identiﬁed by sequential Southern hybridization
using telomere adjacent probes. Putative single fusion
molecules were re-ampliﬁed with nested PCR primers
and in order to identify the fusion points as well as
the speciﬁc telomeres involved in each event, multiple
sequencing reactions were undertaken for each fusion
product. We sequenced a total of 298 fusion events; 125
events from HEK293 cells (of which n=41 and n=84
were from the 16p and 21q groups, respectively) and 173
events from MRC5 cells (of which n=71 and n=102
were from the 16p and 21q, groups, respectively).
Fusions were detected between either 17p or XpYp and
several telomeres within the 21q and 16p families. This
demonstrated that our assays were capable of detecting
fusion between the multiple chromosome ends targeted
in the assay.
Table 1. Oligonucleotide sequences for fusion analysis
Fusion PCR
21q1: 50-CTTGGTGTCGAGAGAGGTAG-30
16p1: 50-TGGACTTCTCACTTCTAGGGCAG-30
Sequencing
16pseq1: 50-TGCCTCACCTCTCTGGGCCAG-30
XqYqseq2: 50-GTTGCTCTGACATGGACACAG-30
16pseq4: 50-TGGGTCCTGGCAACACTCTG-30
16p2seqB: 50-GCTCCAGATGACATCACAGGG-30
16p6: 50-CTCCACTCCAGTGCTCAGCTTG-30
16p2: 50- TCACTGCTGTATCTCCCAGTG -30
1pseq2BT: 50-TGCAGCTGCCTGTCAGGAAG-30
1pseqA: 50-TCAGTGACAGACACGGGGTCTC-30
16pseq1rev: 50-GCTGGGTGAGCTTAGAGAGGAAAGC-30
16pseq3: 50-TCCAGGGCTTCACCTGCTAG-30
16p5: 50-TAGCATGTGTCTCTGCGCCTG-30
21q2CT: 50 -AGTAGCATCTCYAGTGCTGGAG-30
21qseq1: 50-TGGTCTTATACACTGTGTTC -30
21q3: 50-CTGCAGTTGTCCTAGTCGC-30
10q1: 50-AGGTTCCACTCGTCTCTGCG-30
10q2: 50-TGCAATGTCCCTAGCTGCCAG-30
8p1: 50-TGCACAGGACTCTTAGGCTG-30
Subtel2: 50-GAATCCTGCGCACCGAGATTCTC-30
21qseq2: 50-TGCCCCAATCATCATTCACTCTGC-30
21qseq1rev: 50-AGCTAGCTATCTACTCTAACAGAGC-30
6p1: 50-CTGCACAGGACTCCTAGGATG-30
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The sequence analysis revealed that all the fusion
events involved the deletion of either one or both of
the telomeres, these deletion events extended into the
telomere-adjacent DNA. Using the 16p group assay,
which extends the furthest from the start of the
telomere, we detected fusion events close to the limit of
the assay, 6.1kb (Figures 2A and 3A). Both the MRC5
and HEK293 cells displayed similar deletion proﬁles
(P=0.65) with combined mean deletion size of
2.443kb±1.540 (SD) (Figure 3A). Similar deletion
proﬁles were apparent at the other chromosome ends
analysed in the 21q group, XpYp and 17p (Figure 3
B–D). The highest frequency of fusion (mode) occurred
within 0.2–2kb of the telomeres; however these data were
not normally distributed (Figures 3A–D, P<0.0008,
Shapiro–Wilk normality test) and distal to the mode the
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Figure 2. Examples of the DNA sequences telomere fusion events. (A) XpYp:XqYq, showing a deletion of 5601bp in the XqYq telomere-adjacent
DNA and fusion between two arms of the same chromosome. (B) 17p:10q, showing telomere TTAGGG repeats on either side of the fusion point.
(C) 17p:2q14, example of fusion with an interstitial telomeric locus. (D) XpYp:10q, an example of a large insertion of non-telomeric DNA derived
from 8q24. (E) 1p:XpYp, an example of an insertion from the same telomere (XpYp) in reverse orientation, SNPs that identify the XpYp
telomeric-allele involved in the fusion event are identiﬁed with arrows above the sequence. (F) XpYp:XqYq, an example of a small insertion as
well as fusion between two arms of the same chromosome. Telomere-adjacent DNA is shown in the multicolour, insertions in brown, TTAGGG
repeats in black and telomere repeat variants in red. The number of contiguous blocks of TTAGGG (T) and variants (V) are detailed below each
sequence.
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per unit length. These proﬁles indicate that sub-telomeric
deletion prior to the fusion may be more extensive than
that detected here, extending up to and beyond the limit
of our assays.
In addition to the characteristic deletion events that
accompany telomere fusion, the majority of fusion
events (60–74% in HEK293 and MRC5 respectively)
exhibited short patches (1–12nt, overall mean 1.7nt)
of 100% sequence homology (Figure 3E). Compared to
the A:T/G:C content of the telomere-adjacent sequences
studied here (48% A:T, 52% G:C) there was a signiﬁcant
bias towards G:C base pairs within the regions of
microhomology at the fusion points (39% A:T, 61%
G:C, P=0.002 chi-square).
Telomere length and fusion
The frequency of fusion increased in the MRC5 E6E7 cells
with ongoing cell division as the cells approached crisis
(Figure 1B). Interestingly, these cells displayed fusion
between either XpYp or 17p and just two of the nine
telomeres within the 21q group (10q and 21q); this was
in contrast to the HEK293 cells where fusion was detected
involving seven diﬀerent telomeres in the 21q group. This
indicated that in MRC5 cells a speciﬁc subset of telomeres
may have eroded to a length at which they became sub-
jected to fusion, whereas the other chromosome ends
within the 21q family had not.
The TTAGGG telomere repeat content at the fusion
junctions was limited, with 38% to 60% of fusions in
the HEK293 and MRC5 cells, respectively containing no
telomere repeats (Figure 3F). Of the fusions that did
contain TTAGGG repeats immediately adjacent to
the fusion point, the mean length was 5.8±0.7 (SE)
repeats. Single examples of longer segments of contiguous
TTAGGG repeats adjacent to the fusion point were also
observed with the largest block of 43 repeats observed in
MRC5 cells; further sampling may yield longer telomeres
involved in fusion (Figure 3F). Just one fusion event of the
total 298 sequenced revealed telomere repeats on each side
of the fusion point, in this case 6.5 repeats from 17p and
3.5 repeats from 10q (Figure 2B). This was consistent with
our previous observations, where the paucity of fusion
events containing telomere repeats on either side of the
fusion point was not accounted for by the resulting
inverted repeats being refractory to PCR (2).
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Figure 3. Histograms summarizing the data from the telomere fusion analysis in telomerase-positive epithelial HEK293 (open bars) and
telomerase-negative MRC5 cells expressing HPV oncoproteins E6E7 from all three PD points sampled (solid bars). (A–D) The deletion size from
the start of the telomere repeat arrays for16p group, 21q group, XpYp and 17p, respectively. (E) Size of 100% sequence homology at the fusion
point. (F) Number of contiguous TTAGGG repeats at the fusion point. Means±SD for each data set are indicated.
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hyper-variable interspersion patterns of the canonical
telomere repeat sequence TTAGGG with telomere
repeat variants (37,43,44). Our large data set of single-
molecule fusion sequences involving the XpYp and 17p
telomeres, allowed us to examine in detail the telomere
variant repeat (TVR) composition derived from single
cells within the same cell strain. These regions contain
numerous diﬀerent types of telomere repeat variants
interspersed with TTAGGG repeats, some of which are
in contiguous blocks up to 16 repeats in length within
the alleles described here (Figure 4 and Supplementary
Figure S1). It was apparent from this analysis that the
majority of fusions that contain TTAGGG repeats
adjacent to the fusion point were derived from within
the TVR regions; the TVR regions are not considered to
constitute functional telomere repeat regions (2). Out of
201 fusion events in which the TVR region could be doc-
umented only 29 (14%) displayed a fusion point that was
distal to the TVR region (Supplementary Figure S1).
The TVR data also revealed a further aspect of
mutation within telomere repeat arrays. We documented
26 diﬀerent telomere variant repeat types at the XpYp and
17p telomeres in MRC5 and HEK293 cells. In addition,
we observed that the same allele sequenced from separate
cells within the same cell strain, exhibited diﬀerences
within the repeat distributions (Figure 4 and Supplemen-
tary Figure S1). These diﬀerences could be attributed
to single base insertions or deletions, converting one
pre-existing repeat to another, for example TTAGGG to
TAGGG, and expansions or contractions in the size of
contiguous repeat blocks which include duplications as
well as larger deletions of up to 31 repeats (168bp)
(Figure 4). Many of the repeat changes were detected in
more than one independent fusion event and must have
arisen prior to any fusion event. Thus, these mutation
events have not arisen as a consequence of the fusion
event itself and therefore may reﬂect ongoing mutational
processes within these regions of the telomere.
Interestingly, we also observed two fusion events which
KEY
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Figure 4. Examples of the telomere variant repeat structure derived from sequence analysis of the telomeres adjacent to single telomere fusion events.
The telomere codes run left to right (proximal to distal), the fusion point is at the right hand of each code, the numbering above indicates the number
of repeat units from the start of the telomere repeat array. The key indicates the lettering system for each type of telomere repeat variant identiﬁed.
Gaps ( ) in the codes were introduced to improve the alignment, these gaps therefore indicate putative expansions or contractions of repeat blocks.
An example of duplication is indicated with an arrow, deletions and insertions are indicated with parenthesis.
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origin, immediately adjacent to the fusion point
(Figure 4).
Complex fusion events
We observed fusion between both the 17p and XpYp
telomeres and the interstitial ancestral telomere–telomere
fusion at 2q14, this locus is approximately 130Mb from
the 2q telomere (Figure 2C) (42). It could not be deter-
mined whether this represented fusion following a
large-scale subtelomeric deletion process initiated from
the 2q telomere, or fusion directly with a de novo DNA
double-strand break that occurred near this locus;
however, it was clear that dysfunctional telomeres are
capable of fusion to non-telomeric loci. Indeed, we
detected fusion events (34/298, 11%) that contained addi-
tional genomic sequences inserted between the fused
telomeres (Figure 2D). The genomic locus of four inser-
tions could be identiﬁed; one was derived from 8q24.3, one
from 7p21.1 and two from Xp22.1. Interestingly, these
loci, as well as 2q14, are all close to fragile chromosomal
sites (45,46). Two of the insertion events contained
sequences from the originating telomere inserted in the
reverse orientation. In MRC5 cells where the XpYp
telomeric alleles could be identiﬁed by numerous SNPs
in the telomere adjacent DNA (2,37), it was clear that
these inverted insertions were derived from the same
allele involved in the fusion event, and were therefore,
intra-allelic (Figure 2E). The remaining 28 insertion
events were too small to identify the originating chromo-
somal locus (Figure 2F).
We also detected fusion events between the XpYp and
XqYq telomeres in 23 out of the 112 fusion events
sequenced involving the 16p group of telomeres (21%,
Figures 2A and 2F); such events may result in the forma-
tion of ring chromosomes.
DISCUSSION
Here, we have described a comprehensive analysis of
telomere fusion between multiple chromosome ends in
human cells. These assays can detect sister chromatid-type
fusion when there has been a deletion of at least one
of the telomere repeat arrays creating an imperfect
inverted repeat, they can also detect fusion between
heterologous chromosomes containing substantial arrays
of head-to-head telomere repeats that arise following
TRF2 depletion (2). They cannot however, detect the
presence of sister chromatid-type fusions that create
perfect inverted repeat sequences (2). Interestingly,
studies using telomere-adjacent I-SceI induced breaks,
show that the majority (90%) of selected clones had
undergone chromosomal ‘healing’ by the addition of
new telomere (47). Of those clones that had not undergone
chromosomal healing, inverted repeats close to the site
of the original break was the most common event; this is
consistent with sister chromatid fusion (48). The majority
of events that are detected with our assays involved
heterologous chromosomes, with 5% of events that were
consistent with sister chromatid fusion (2). The diﬀerence
between these two datasets may be related to the fact that
our data is examining telomere fusion in the context of
widespread telomeric dysfunction across multiple chromo-
somes, compared to the selection of events involving
breakage at a single chromosome end in the context of
otherwise functional telomeres at the other chromosome
ends.
It is clear from our previous work (2), as well as that
from other labs (48,49), together with the large data set
described here, that the fusion of short dysfunctional
telomeres is accompanied by telomeric and sub-telomeric
deletion. This proﬁle is also consistent with studies using
I-Sce1 induced double-strand breaks where larger dele-
tions were observed at telomeric loci (49). The size
proﬁle of these deletion events indicates that deletion is
likely to extend beyond the proximal limit of our assays,
which at the 16p group is 6.1kb. Whilst the mechanism of
deletion has not been characterized, studies using condi-
tional cdc13 mutants in Saccharomyces cerevisiae show
that the exo1 dependent single-stranded DNA can
extend for at least 8kb from the start of the telomere
(50). Furthermore, breakpoint frequency within the
terminal chromosomal bands observed in pancreatic car-
cinoma and osteosarcoma has been shown to negatively
correlate with telomere length at speciﬁc chromosome
ends (15). This data was determined from karyotype
analysis and therefore the distance of the breakpoints
within the terminal bands may be several mega base
pairs from the chromosomal terminus. Thus, we
consider that the subtelomeric deletion that follows the
formation of short dysfunctional telomeres could be
extensive, and may include terminal coding regions.
Several genes have been identiﬁed close to the telomere,
for example members of the Wiskott–Aldrich Syndrome
Protein and Scar homolog (WASH) gene family lie within
5kb from the start of the telomere repeat array (51).
Therefore, irrespective of whether they undergo fusion,
or healing by de novo telomere formation, the extensive
deletion events that occur at short dysfunctional telomeres
are likely to create a signiﬁcant mutational burden. Indeed
it is clear that terminal chromosomal deletions have been
implicated in numerous clinical genetic conditions (52,53).
The extensive deletion that accompanies telomere
fusion together with microhomology at the fusion junction
may be indicative of the DNA repair processes that
mediate fusion between short dysfunctional telomeres.
The limited homology at the fusion junction, together
with the extensive deletion, appear inconsistent with
single-stranded annealing or NHEJ as being the predom-
inant mechanisms underlying fusion; both these mecha-
nisms have, in diﬀerent contexts, been described to
mediate telomere fusion (23,54). An alternative NHEJ
pathway has been described in mammalian cells (55,56)
that is DNA-PK independent. This pathway is considered
to be error-prone resulting in extensive deletion (55,57)
and is facilitated by microhomology at the fusion point
with a bias toward G:C base pairs (58). The proﬁle that
accompanies DNA-PK-independent NHEJ is reminiscent
of the extensive deletion and microhomology with a
G:C bias described here following the fusion of short
dysfunctional telomeres. This alternative NHEJ pathway
1848 Nucleic Acids Research, 2010,Vol.38, No. 6may account for double-strand break repair in the absence
of functional classical NHEJ in some tumours (59), V(D)J
recombination and IgH class switching in mouse models
(60,61) and thus is physiologically relevant. This pathway
is poorly characterized and the involvement, if any, of
the key proteins required in this pathway such as
PARP-1 and Ligase III (62–64), in telomere fusion, has
yet to be established. It will be of interest to ascertain
which pathway mediates the fusion between short
dysfunctional telomeres.
We observed fusion events in which there was an inser-
tion of additional telomere-adjacent DNA, which was
derived from one of the two telomeres involved in the
fusion event. Informative SNPs allowed us to establish
that the inserted DNA was derived from the same
telomeric allele involved in the fusion event and it was
therefore an intra-allelic event. Furthermore, in all the
examples of this type of fusion, the DNA was inserted
in the reverse orientation with respect to the telomere
repeat array. These observations lead us to consider that
the fusion event involved an intra-molecular rearrange-
ment prior to the ﬁnal fusion between the two chromo-
somes. We propose the following sequence of events as
illustrated in Figure 5, as a speculative model to account
for both the presence of multiple fusion points within the
same single molecule and the reverse orientation of the
insertion. In this model short telomeres lose their end pro-
tection function, possibly because of a lack of TRF1 and
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Figure 5. Illustrating a model, for the sequence of events, that may account for intra-allelic inverted insertion that accompanies a subset of telomere
fusion events. This model is using the fusion sequence depicted in Figure 2F as an example, the deletion points are indicated as distances from the
start of the telomere repeat array. (A–B) Short telomeres become de-protected and are subjected to nucleolytic resection, yielding a 30-overhang
within the telomere-adjacent DNA. (C) The 30-end of the overhang ( 111) folds back upon itself and anneals adjacent to the  596 position, this is
ligated and endonucleolytic cleavage creates a 50-overhang structure which can be rendered double-stranded by strand extension (D). Further
resection (E) to the  356 position creates a substrate (F) for annealing and ligation of the 1p sub-telomere at position  1260 (G).
Endonucleolytic cleavage removes the unpaired 30-overhang from XpYp (G), strand extension and ligation complete the fusion (H–I).
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extensive resection creating a region of single-stranded
DNA (Figure 5A–B). The 30-end of this single-stranded
DNA folds back upon itself and anneals at points of
microhomology that are suﬃciently stable to facilitate
ligation (Figure 5C). The intra-molecular loop is then pro-
cessed by endonucleolytic cleavage to create a 50-overhang
with the inversion and one fusion junction in place
(Figure 5D). The 50-overhang is then rendered
double-stranded by strand extension, and subjected to
further 50–30 resection to create a substrate for fusion
(Figure 5E–F) with another telomere or double-stranded
DNA break (Figure 5G–I). An alternative mechanism as
elaborated previously (20,21,49) could involve an initial
sister chromatid fusion. This creates an imperfect
inverted repeat which forms a fragile site that breaks fol-
lowing anaphase bridging close to the site of the ﬁrst
fusion, this broken end now contains an inversion which
then fuses to the second chromosome involved in the
fusion event.
We observed numerous examples of fusion between
XpYp and XqYq; such events have the potential to
create circular chromosomes. These ring chromosomes
can occur constitutively, resulting in variable clinical con-
sequences which is not consistent with a loss of genetic
material in the originating ring chromosome (65,66).
Some examples of ring chromosomes, such as ring chro-
mosome 19, indicate they have formed as a consequence of
telomere fusion without any cytogenetically detectable
terminal deletion (67). Thus, it has been postulated that
‘ring syndromes’ result from the subsequent mitotic insta-
bility of the ring chromosome (66). Ring chromosomes are
also frequently detected in tumour cells, and have been
shown to be highly unstable and undergo continuous
rearrangements (68); resulting in potentially oncogenic
ampliﬁcation and deletion (69). Interestingly, some
tumour types for example liposarcomas and parosteal
osteosarcoma exhibit ring chromosomes in over 90% of
tumours (70–72). Whereas other cancer types, including
many types of carcinoma, the frequency of ring chromo-
somes is much less <10% of cases (72).
Extensive variation in the human population in the dis-
tribution patterns of telomere repeat variants that occur
in the proximal 2–3kb of telomere repeat arrays has been
described (37,44). Diﬀerences in the TVR distributions of
related telomeric alleles indicate a pattern of intra-allelic
mutation, which is remarkably similar to that as described
here in the TVR distributions obtained from single cells
of the same cell strain. The patterns of mutation, including
repeat expansion and contraction, and mutation within
the telomere repeats themselves, are consistent with
errors during replication such as stuttering of the replica-
tion fork. Consistent with this, telomere repeat arrays, as
well as other repetitive loci, present a problem for the
replication fork, and as such, require additional process-
ing to facilitate progression (73–75).
Analysis of the TVR distributions also revealed the
presence of two fusions with additional repeat variants
immediately adjacent to the fusion point; these did not
appear to be derived from the progenitor allele. We con-
sidered that this may be related to the process of fusion,
with the possibility of processing of a heteroduplex at the
fusion point creating a scrambled repeat structure;
however, this appeared unlikely as the general repeat
structure was conserved and the DNA sequence of the
participating chromosome did not contain the correct
bases. Instead, we consider that these inserted repeats
may represent an insertion of additional DNA derived
from another telomere during the fusion event.
All the fusion events that involved non-telomeric loci,
2q14, 8q24.3, 7p21.1 and Xp22.1, where identiﬁed within
the same cytogenetic location as previously documented
fragile sites (45,46). In contrast to normal cells, fragile sites
are involved in chromosomal rearrangements in tumour
cells, these are typically deletions, but translocations
involving fragile sites have also been identiﬁed (76–78).
The fusion of short dysfunctional telomeres with fragile
sites may thus provide one mechanism to generate
large-scale genomic rearrangements in cancer cells.
Whatever the underlying mechanisms that generate the
fusion structures described here, it is clear from this data,
that short dysfunctional telomeres can be subjected to
considerable processing prior to fusion, creating complex
structures and substantial deletion.
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